Company Profile
Updated: 10-NOV-09Opexa Therapeutics Inc.
Public Company, Headquarters Location
2635 N Crescent Ridge Dr., The Woodlands, TX 77381-3905, United States
(281)272-9331, (281)272-1088 fax, http://www.opexatherapeutics.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Wholesale: Distributor of sportstrading cards, memorabilia, and sports and related merchandise to include novelties, apparel and collectibles.Manufacturing: Pharmaceutical preparations.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin[R] Development in Multiple Sclerosis.
Clinical Trials Week; 12/14/2009; 1424 words; Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company...Chief Medical Officer (see also Opexa Therapeutics, Inc.). Jaye Thompson adds considerable...patients in need." About Opexa Opexa Therapeutics, Inc. is dedicated to the development...
OPEXA THERAPEUTICS, INC. ANNOUNCES $5.1 MLN SECURITIES OFFER.
AsiaPulse News; 12/11/2009; 1500 words; ...NASDAQ) (RODM.NASDAQ) Opexa Therapeutics, Inc. Announces $5.1 Million...Dec. 10, 2009--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a...NY 10020. About Opexa Opexa Therapeutics, Inc. is dedicated to the development...
BUSINESS WIRE DAILY SUMMARY - DEC 10, 2009.
AsiaPulse News; 12/11/2009; 1618 words; ...English). 6) Category Code: Pharmaceutical OPEXA THERAPEUTICS, INC. ANNOUNCES $5.1 MILLION SECURITIES OFFERING Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a novel...
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering.
Business Wire; 12/10/2009; 1372 words; THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a...Americas, 20th Floor, New York, NY 10020. About Opexa Opexa Therapeutics, Inc. is dedicated to the development of patient...
Research and Markets Offers Report: Global Stem Cell and Advanced Technologies Market
Wireless News; 12/8/2009; 793 words; ...Intercytex - Medistem Inc - Mesoblast Ltd - Multicell Technologies, Inc - Neostem - Novocell Inc - Neuralstem Biopharmaceuticals, Ltd. - Opexa Therapeutics - Osiris Therapeutics, Inc - Plureon Corp - Pluristem Therapeutics - Reneuron, Inc - Stemcells...
Recent News Articles
- www.StockMarketingInc.com :: Presents :: (Nasdaq:OPXA) Opexa Therapeutics, Inc., (Pinksheet:WDRP) Wanderport Corp., (OTCBB:IVOB) INVO BioScience, Inc., (Nasdaq:GNBT) Generex Biotechnology Corp.
M2 Presswire - August 07, 2009 - Emergingstockreport.com initiates (complimentary) research coverage on: Opexa Therapeutics, Inc. (NASDAQ: OPXA).
M2 Presswire - June 10, 2009 - Opexa Therapeutics, Inc. (NASDAQ: OPXA) We have picks that move!
M2 Presswire - June 09, 2009 - Opexa Therapeutics Inc-Financial Company Report.
M2 Presswire - February 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning